ArticleFrontiers in oncology2026
Multitask learning for early treatment response and survival prediction in lung cancer radiotherapy using sequential CBCT imaging.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adaptive radiotherapy requires early prediction of treatment response and survival, yet the optimal use of longitudinal cone-beam computed tomography (CBCT) imaging and modeling strategy for small cohorts remains unclear. Purpose: To develop a multitask deep learning framework for simultaneous treatment response classification and progression-free survival (PFS) prediction using planning computed tomography (CT), dose, and sequential CBCT, and to evaluate the impact of including different numbers of early CBCT time points on prediction performance within an incremental analysis framework. Methods: A total of 142 lung cancer patients were retrospectively analyzed. A lightweight network with cross-modal attention fusion and dual task heads for treatment response classification and Cox-based survival prediction was trained end-to-end and benchmarked against 12 baseline methods via 5-fold cross-validation. Results: Using only the first on-treatment CBCT, the model achieved an area under the receiver operating characteristic curve (AUC) of 0.858 ± 0.078 and a concordance index (C-index) of 0.672 ± 0.058, outperforming all baselines. Ablation analysis confirmed the contributions of attention fusion and multitask training. Additional CBCT scans degraded classification performance, likely due to increased dimensionality relative to the cohort size. Conclusions: The first on-treatment CBCT provided the strongest early predictive signal for treatment response classification in this cohort; adding subsequent scans degraded classification performance and produced only a marginal change in survival concordance under the current study setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.